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ABSTRACT
The endogenous human telomerase reverse
transcriptase (hTERT) gene is repressed in somatic
cells. To study the mechanisms of its repression,
we developed a strategy of retrovirus-directed Cre
recombinase-mediated BAC targeting, or RMBT,
to generate single-copy integrations of BAC at
pre-engineered chromosomal sites. This technique
involved retroviral transduction of acceptor loci,
containing an HSV thymidine kinase marker, and
subsequent integration of BAC constructs into the
acceptor sites, utilizing the loxP and lox511 sites
present in the vector backbones. The BAC reporter,
with a Renilla luciferase cassette inserted down-
stream of the hTERT promoter, was retrofitted
with a puromycin marker. Through puromycin selec-
tion and ganciclovir counter-selection, a targeting
efficiency of over 50% was achieved. We demon-
strated that the activity and chromatin structures
of the hTERT promoter in chromosomally integrated
BAC reporter recapitulated its endogenous counter-
part of the host cells. Therefore, we have estab-
lished a genetically amendable platform to study
chromatin and epigenetic regulation of the hTERT
gene. The highly efficient and versatile RMBT tech-
nique has general applicability for studying largely
unexplored chromatin-dependent mechanisms of
promoter regulation of various genes.
INTRODUCTION
Transcriptional regulation of gene expression is cen-
tral to development, cell diﬀerentiation, and disease
progression (1,2). Cumulative evidence has indicated
that epigenetic and chromatin-dependent mechanisms
play critical roles in regulating gene activities (3,4). For
example, in addition to transcription factors that directly
bind DNA, compositions and covalent modiﬁcations
of histones, organization of nucleosomal structures, and
DNA methylation are all playing vital roles in gene
regulation.
Currently, transient transfection of small plasmid
reporters is the most commonly used approach for analyz-
ing cis-regulatory elements. Using this method, a large
body of data has been accumulated on the structural
and functional studies of cis-elements in the regulation
of promoter activities. However, nucleoprotein complexes
formed by transiently transfected plasmids were diﬀerent
from nucleosomes at the native loci (5). They had altered
histone H1 stoichiometry and lacked nucleosome position-
ing (6). In addition, the transient transfection method
could yield erroneous results, due to frequent formation
of concatamers between cotransfected plasmid DNAs
through non-homologous end-joining ligation (7), further
complicating the interpretation of results from experi-
ments involving cotransfection of a control reporter
plasmid, a commonly used strategy.
Many cis-elements regulating local chromatin environ-
ment have been identiﬁed (8,9). Transient transfection
assays are unsuitable for studying such elements. At pres-
ent, methods to examine these chromatin elements are
limited. For example, chromatin boundary elements or
insulators are often taken out of their normal chromo-
somal contexts and tested in small plasmids for their abil-
ity to generate drug-resistant colonies (10). In many cases,
the roles of such elements in their native chromatin
context remain to be veriﬁed.
The hTERT gene, which encodes human telomerase
reverse transcriptase, is silenced in most somatic cells
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We and others have previously reported that transiently
transfected plasmid reporters containing the hTERT pro-
moter did not recapitulate the endogenous promoter in
several ﬁbroblast lines, suggesting that distal-regulatory
elements and/or native chromatin environment were
required for its regulation (11–13). Ideally, one would
like to directly analyze the endogenous hTERT locus to
delineate cis-regulatory elements. However, any modiﬁca-
tions of a native gene are technically arduous, if not
impossible, by known methods, including homologous
recombination that occurs at an extremely low eﬃciency
in human somatic cells. Thus, it would be important to
develop an hTERT reporter system that recapitulates its
native chromatin context. First, such a reporter system
should contain a large segment of genomic sequence
including distal regulatory elements that are often dis-
persed in regions exceeding 100kb. A large DNA con-
struct, such as a bacterial artiﬁcial chromosome (BAC)
that encompasses several loci, likely contains suﬃcient
information to establish a chromatin environment similar
to the native loci upon chromosomal integration. Second,
this reporter should be integrated, preferably as a single-
copy, into a pre-determined chromosomal acceptor site,
allowing its mutant derivatives to be analyzed with iden-
tical genomic contexts. A number of recombination-based
technologies are now available, such as BAC recombineer-
ing and heterologous site-speciﬁc recombination, making
it feasible to develop such a system (14–18). In particular,
heterologous site-speciﬁc recombinase (SSR, e.g. Cre, FLP
and øC31) could catalyze eﬃcient exchange of sequence
cassettes at targeted chromosomal loci, a process known
as recombinase-mediated cassette exchange (RMCE) (19).
Indeed, several groups have succeeded in targeted inser-
tion of various large DNA constructs, including BAC
constructs, into pre-selected chromosomal sites in mam-
malian cell lines by using SSRs (20–24). This type of
precise chromosomal integration would allow detailed
mutagenesis studies of a chromatinized reporter at speciﬁc
chromosomal sites.
To study the mechanisms of hTERT gene regulation in
a relevant chromatin context, we developed a retrovirus-
directed and recombination-mediated BAC targeting
(RMBT) strategy to speciﬁcally integrate a modiﬁed
BAC construct into pre-engineered chromosomal sites.
We demonstrated that the targeting process was highly
eﬃcient despite that large BAC constructs were used.
Upon chromosomal integration, the BAC construct
containing the hTERT locus adopted a chromatin conﬁg-
uration similar to its native counterpart. The expression
of integrated hTERT promoter closely resembled that of
the endogenous promoter in the host cells. The minor
variations of hTERT-promoter activity among indepen-
dently targeted BAC reporter clones at the same integra-
tion sites were eliminated by a transient treatment of
5-azacytidine, an inhibitor of DNA methyltransferases.
Therefore, our data revealed, for the ﬁrst time, that the
chromatin-dependent regulation of the hTERT promoter
was re-established by inserting a large segment of human
genomic DNA containing the hTERT locus into hetero-
logous chromosomal sites in human cells.
MATERIALS AND METHODS
Plasmids and BACs
The construction of acceptor plasmid pML-2 is described
in Supplementary Table S1. BAC reporter constructs
117B23cFtRvSVP (Figure 1) and 183M22cFtRvSVP
were generated from the original BAC clones RPCI11-
117B23 and RP24-183M22 (BACPAC Resources Center
at Children’s Hospital Oakland Research Institute,
Oakland, CA). These reporters were constructed through
a two-step recombination procedure (25), which was based
on a BAC recombineering protocol from the Copeland lab
(26). In this procedure, an rpsL
+-kanamycin marker was
ﬁrst inserted into the site of modiﬁcation by selecting
for kanamycin resistance and subsequently replaced with
a luciferase cassette by selecting against streptomycin
sensitivity (Supplementary Figure S1), resulting in precise
modiﬁcations without any unwanted sequences. The
puromycin resistant marker was inserted into the vector
backbone using a kanamycin selection marker, which was
deleted via FLP-induced recombination in bacterial host
EL350. Following each recombineering step, the modiﬁed
BAC constructs were examined by digestion with at least
four diﬀerent restriction enzymes to ensure that only
intended recombinations occurred, which were further
conﬁrmed by sequencing the junctions. For transfection,
high quality BAC DNAs were prepared using a Genopure
Plasmid Maxi kit (Roche) and examined by pulse ﬁeld gel
electrophoresis to ensure the integrity.
Cell culture and transfections
Immortal human ﬁbroblast cell lines (13) were cultured in
minimal essential medium containing 10% fetal bovine
serum. Transfections were performed using FuGene 6 or
FuGene HD reagent according to the manufacturer’s
recommendations (Roche). For stable clones, cells were
selected ﬁrst with 0.5mg/ml puromycin for 3 days,
followed by selection in 25mM ganciclovir for 48h. For
5-azacytidine treatment, cells were plated in 6-well plates
at 30% conﬂuence and treated with 0.5mM 5-azacytidine
(5-AC) (Sigma) the next day continuously for 9 days.
Luciferase assays were performed before, at 9 days of
treatment, 12 days and 20 days after the completion of
treatment.
Gene expression analyses
For qRT–PCR, RNA isolation and cDNA synthesis were
performed as described previously (27). Real-time PCR
was performed in triplicates using an ABI StepOnePlus
system. PCR primers and Taqman probes are summarized
in Supplementary Table S2. Luciferase assays were
performed as described previously (28). Luciferase activ-
ities were normalized to cell viability, as determined by
thiazolyl blue tetrazolium bromide (MTT) assays (29).
Southern blotting and DNase I sensitivity assays
For characterization of acceptor loci and targeted BAC
integrations, 3–5mg genomic DNAs were digested with
various restriction enzymes and Southern blots were
hybridized to chicken b-globin insulator sequence cHS4
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For DNase I assays, nuclei preparation and genomic
DNA extraction were performed as previously described
(13,27).
RESULTS
Construction of a BAC reporter for monitoring
transcriptional regulation of the hTERT gene
It has been previously shown that transiently transfected
small plasmid reporters containing the hTERT promoter
failed to recapitulate the endogenous hTERT gene expres-
sion (11,13). In fact, we have shown that chromatin envi-
ronment played an important role in the regulation of
the hTERT gene (27,30). In order to further study its reg-
ulatory mechanisms in depth, we constructed a reporter
from a BAC clone (RPCI11-117B23) containing 160kb of
human genomic sequence, including the entire hTERT
gene, the upstream CRR9 locus, and the downstream
Xtrp2 locus (Figure 1). The CRR9 gene is constitutively
expressed in all cell types examined, whereas expression of
the Xtrp2 gene is only detected in kidney-derived cells
(27,31). Because both upstream and downstream loci
have very diﬀerent expression patterns compared to the
hTERT gene, this BAC presumably contains all the essen-
tial cis-regulatory elements for the correct regulation of
hTERT gene.
For convenient and quantitative measurement of the
hTERT promoter activity, a codon-optimized Renilla
(Rluc) and a Fireﬂy (Fluc) luciferase expression cassette
were inserted into the initiation codons of the hTERT
and CRR9 genes, respectively (Figure 1 and Supplemen-
tary Figure S1). The Fluc transcribed from the constitu-
tive CRR9 promoter was intended to be an internal
control for determining the relative level of hTERT pro-
moter activity. For selection of BAC containing cells,
a cassette containing a puromycin marker driven by
the SV40 promoter and a kanamycin resistance gene
surrounded by two FRT sites, was placed within the
pBACe3.6 vector backbone immediately downstream of
the lox511 site (Figure 1 and Supplementary Figure S1).
The kanamycin marker was subsequently removed
via FLP recombinase-mediated recombination (26).
The ﬁnal BAC reporter construct, 117B23cFtRvSVP, is
shown in Figure 1.
Experimental strategy of targeted BAC integration
To develop a controlled BAC integration method,
we designed a two-step BAC targeting scheme, RMBT,
involving the establishment of pre-determined acceptor
cell lines and subsequent site-directed chromosomal inte-
grations of BAC reporter constructs (Figure 2). pBACe3.6
and pTARBAC1, the vector backbones used in the major-
ity of currently available BAC libraries, had two lox sites,
a lox511 and a loxP site (32). To make use of these sites
for chromosomal integration, an acceptor vector, pML-2,
was constructed (Figure 2A and Supplementary Table S1).
pML-2 is a retroviral vector that contained a tkNeo ORF,
a fusion protein of the HSV-thymidine kinase and neomy-
cin resistance gene (33), and a CreER ORF, a fusion
protein of Cre recombinase and the hormone-binding
domain of human estrogen receptor. These two ORFs,
separated by an internal ribosomal entry site (IRES),
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Figure 2. Strategy of retrovirus-directed recombinase-mediated targeted
BAC targeting (RMBT). (A) Acceptor retroviral vector pML-2. The 50
LTR contains U3, R, and U5 elements, whereas U3 in the 30 LTR was
replaced by a 1.2-kb chicken b-globin insulator, cHS4 (Ins). (B) Cre-lox
mediated recombination between a proviral acceptor locus and a BAC
reporter. Following retroviral replication, the 50 LTR is replaced by the
30 LTR. (C) The integrated BAC reporter. Open and closed triangles
mark the positions and orientations of lox511 and loxP sites, respec-
tively. CMV, the cytomegalovirus major promoter; tkNeo, a fusion
protein of herpes simplex virus thymidine kinase and neomycin-resis-
tant protein; ires, internal ribosomal entry site; CreER, a fusion protein
of Cre-recombinase and the hormone-binding domain of human estro-
gen receptor; P, puromycin-resistant marker. Thick gray lines represent
the human sequences in the BAC construct; wavy lines, endogenous
chromosomal sequences.
CRR9 hTERT Xtrp2
RLuc FLuc Puro
Xtrp2-like
10 kb
Figure 1. A schematic illustration of the BAC reporter 117B23cFtRvSVP containing the hTERT, CRR9 and Xtrp2 loci. Exons are designated as long
vertical bars and lines. Short black rectangles represent repetitive elements and short gray rectangles are mini-satellite sequences. Horizontal arrows
indicate the directions of transcription. Fluc and Rluc, the Fireﬂy and codo-optimized Renilla luciferase expression cassettes, respectively. Puro, the
puromycin-resistant gene controlled by the SV40 promoter. The open and closed triangles show the positions and orientations of loxP and lox511
sites, respectively.
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cassette was ‘ﬂoxed’ by lox511 and loxP sites so that
their recombinations with the lox sites in a BAC would
lead to the replacement of the selection cassette by the
entire insert of the BAC construct (Figure 2B). Cre recom-
binase catalyzes eﬃcient homo-speciﬁc recombination of
both loxP and lox511 sites with no observable in vivo
hetero-speciﬁc recombination between them (34).
Finally, an 1.2-kb insulator, containing the cHS4 element
of the chicken b-globin locus (35), was inserted into the
enhancer-less U3 region of the 30 LTR. During retroviral
transduction, the 30LTR was copied to the 50 end, inacti-
vating the retroviral promoter and surrounding the entire
vector by insulators, and thus shielding the acceptor locus
from possible chromosomal positional eﬀects [Figure 2C
and (36)].
Establishment of acceptor lines
To test the RMBT strategy, we chose to use a pair of
immortal ﬁbroblast lines, telomerase-positive (tel
+)
3C167b and telomerase-negative (tel
 ) 3C166a, which
were derived from a common parental pre-crisis strain
3C (13). Another pair of cell lines, the tel
+ GM639 and
tel
  GM847, were also used (37). Retroviruses derived
from pML-2 were used to infect immortal cell lines at a
low MOI (multiplicity of infection), minimizing multiple
proviral insertions within a single cell. Stable neomycin-
resistant clones were isolated and the copy number of
proviral integrations in each clone was determined by
Southern analysis (Figure 3A), in which Pvu II-digested
genomic DNA fragments were hybridized to a portion
of chicken b-globin insulator sequence. In more than
half of the isolated clones, single proviral integrations
occurred, which resulted in an internal DNA band of
1.0kb and an external band of variable sizes. Two to
three clones with single insertions of pML-2 provirus
were utilized for the subsequent BAC targeting
experiments.
Chromosomal targeting of BAC reporter construct
To target the hTERT BAC reporter 117B23cFtRvSVP
into an acceptor site, the circular BAC DNA was trans-
fected into the acceptor cells. Although tamoxifen (4-HT)
was able to induce Cre recombinase activity in acceptor
cells (data not shown), we found that 4-HT treatment of
transfected cells caused signiﬁcant cell death in some of
the host cell lines. We therefore opted to use a cotrans-
fected Cre-expressing plasmid pCBM to supply the Cre
recombinase. Transfected cells were initially selected
with puromycin for three days, followed by recovery in
drug-free medium until visible colonies were formed.
About one week after transfection, ganciclovir (GCV)
was added to the cells for 48h to select for recombinant
clones that had lost the tkNeo marker. Many of the initial
puromycin-resistant colonies died upon GCV treatment
and therefore contained randomly integrated BACs.
The colonies that survived both puromycin and GCV
selections were isolated, which presumably had undergone
speciﬁc recombination events at the acceptor locus. About
80% of these dual drug resistant clones expressed both
Fluc and Rluc, indicating that they likely contained
the entire BAC reporter sequences (Table 1).
To conﬁrm that the BAC reporter was targeted into the
acceptor loci, genomic DNAs of a subset of luciferase-
expressing clones were digested with AlwN I and analyzed
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Figure 3. Southern analyses of acceptor loci and targeted BAC integra-
tions. (A) Analysis of proviral acceptor loci. Upper panel is a diagram
of a proviral acceptor locus following retroviral transduction.
Horizontal arrows indicate defective LTR elements in which the U3
regions are replaced by the insulator cHS4 (Ins). Lox511 and loxP
sites are shown as open and closed triangles, respectively. Lower
panel shows a representative Southern analysis of acceptor loci.
Genomic DNAs were digested with Pvu II and hybridized to a
32P-
labeled Pvu II-Hind III fragment of cHS4. MW, molecular weight
markers in kilo base pairs. Stars mark the acceptor clones with a
single-copy provirus. (B) Analysis of integrated BAC constructs.
Upper panel illustrates an acceptor locus before and after targeted
BAC integration. The integrated BAC is shown as a gray thick line.
Sizes of internal genomic bands recognized by the insulator probe are
also indicated. Lower panels show representative Southern analyses of
BAC constructs integrated into acceptor loci in 167b3.1 (left) and
GM847.7 (right) cells. Genomic DNAs were digested with AlwN I
and hybridized to a full-length insulator probe. As indicated by arrow-
heads, the 5.8-kb and 1.2-kb internal bands changed to 5.6kb and
2.5kb, respectively, upon integration of the BAC, whereas the two
external bands speciﬁc to each acceptor locus were not aﬀected. The
positions of the Southern probe are shown as horizontal bars below the
diagram. Asterisk indicates clones with targeted integration of the BAC
reporter.
e111 Nucleic Acids Research, 2009, Vol. 37,No. 17 PAGE4 OF10by Southern analysis using the chicken b-globin insulator
as a probe. Shown in Figure 3B is a representative exper-
iment of such analyses for acceptor lines 167b3.1 (left
panel) and GM847.7 (right panel). In each case, four
genomic fragments were detected from the acceptor loci,
including two internal (1.2 and 5.8kb) and two variable
external fragments. Upon Cre-mediated recombination
with the BAC reporter construct, the two internal bands
changed to 2.5kb and 5.6kb, respectively, whereas the
external bands remained the same. The integrity of inte-
grated BAC reporters in a subset of these targeted clones
was further veriﬁed by Southern analyses using multiple
probes speciﬁc for diﬀerent regions of the BAC reporter,
including the hTERT and CRR9 promoter regions (data
not shown). Although most puromycin and GCV resistant
clones contained correctly targeted BAC reporter, some
were not targeted. These non-targeted clones were likely
escapers resulted from either epigenetic silencing of the
CMV promoter in the acceptor locus (#5, Figure 3B) or
loss of the acceptor locus (#7, Figure 3B), both leading to
the loss of GCV sensitivity.
Successfully targeted integrations have been achieved in
acceptor cell lines derived from tel
+ 3C167b and GM639
and tel
  3C166a and GM847 cells (Table 1). For the
pBACe3.6-derived plasmid pBACSVpuroF (13.4kb), ﬁve
out of ﬁve puromycin and GCV-resistant GM639.3 clones
(100%) contained targeted integrations. The 173-kb BAC
117B23cFtRvSVP was successfully targeted into multiple
acceptor loci from all these four cell lines. Since the vector
pTARBAC1 was also used in many BAC libraries,
we tested a pTARBAC1-derived BAC RP24-183M22,
which contained 135-kb mouse genomic sequence encom-
passing the mTERT locus and the upstream mCRR9 and
downstream mXtrp2 loci. This BAC clone was similarly
modiﬁed to 183M22cFtRvSVP as the human BAC repor-
ter. As shown in Table 1, the mTERT BAC reporter was
also eﬃciently targeted into two acceptor loci in 3C167b
and GM847 cells. The average BAC targeting eﬃciency
was 58% overall, ranging from 17% to 89% in diﬀerent
acceptor lines, which was increased to 73%, ranging from
42% to 94%, when pre-screened for luciferase expressions.
We also targeted several other BAC constructs and
attained similar eﬃciencies (data not shown). The rela-
tively low targeting eﬃciency of 166a11.1 cells seemed to
be resulted from the nature of these tel
  cells that utilized
alternative lengthening of telomeres, the ALT mechanism.
Continued dying of these cells during passaging made it
diﬃcult to recover and expand the isolated recombinant
clones. Overall, with a combination of positive and nega-
tive selections, single-copy large BAC constructs were eﬃ-
ciently targeted into acceptor loci of various cell types
through Cre-mediated recombination.
Activity of the integrated hTERT promoter in targeted
BAC reporter
To determine the reporter activities in the targeted BAC
clones, transcription from the integrated hTERT or CRR9
promoter was measured using Rluc or Fluc as readouts.
Two independent clones from tel
  GM847.1 cells and ﬁve
from other acceptor lines, including both tel
+ and tel
 
cells, were examined (Table 2). Rluc activity expressed
from the hTERT promoter was much higher in tel
+
3C167b and GM639 cells than in tel
  3C166a and
GM847 cells. On the other hand, Fluc activity expressed
from the CRR9 promoter was similarly high in all cells,
consistent with the constitutive expression pattern of the
CRR9 gene. Therefore, the ratio of Rluc to Fluc activity
was a reliable assessment of the hTERT promoter activity
in the integrated BAC construct. As shown in Table 2, the
ratio of Rluc to Fluc was higher in 167b3.1 clones than in
GM639.3 and GM639.6 clones, consistent with the higher
level of endogenous hTERT mRNA in 3C167b cells than
in GM639 cells, as determined by real-time RT–PCR anal-
ysis. In contrast, 3C166a and GM847 cells expressed very
little hTERT mRNA and consistently, the Rluc to Fluc
ratio was signiﬁcantly lower in these tel
  cells. Further-
more, BAC reporters integrated in diﬀerent acceptor loci
Table 1. Chromosomal targeting of BAC vector and BAC reporter constructs
Cell lines GM639.3 GM639.6 167b3.1 GM847.7 166a11.1 Overall
BAC
Input DNAs pBAC
a
SVpuroF
117B23
cFtRvSVP
117B23
cFtRvSVP
117B23
cFtRvSVP
183M22
cFhRvSVP
117B23
cFtRvSVP
183M22
cFtRvSVP
117B23
cFtRvSVP
targeting
Vector backbone pBACe3.6 pBACe3.6 pBACe3.6 pBACe3.6 pTARBAC1 pBACe3.6 pTARBAC1 pBACe3.6
Total numbers of isolated clones 30 9 20 29 40 18 33 53 202
No. of clones with dual luciferases   92 02 23 7 1 83 2 2 21 6 0
No. of clones examined by
Southern analysis
b 5 9 14 16 16 13 16 12 96
No. of clones with targeted
integration 5 8 9 15 14 8 11 5 70
Targeting eﬃciencies among
luciferase-positive clones
c   89% 64% 94% 88% 62% 69% 42% 73%
Targeting eﬃciencies among
all clones
d 100% 89% 64% 71% 81% 62% 67% 17% 58%
aA plasmid of 13.4kb.
bOnly a subset of luciferase-expressing clones were examined by Southern analysis.
cTargeting eﬃciencies=numbers of targeted integration/numbers of clones examined by Southern analysis.
dTargeting eﬃciencies=eﬃciencies among luciferase-positive clones   number of clones with luciferases/total number of isolated clones.
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cating that the strong chicken b-globin insulator placed
on both sides of the acceptor loci likely protected the
integrated BAC reporter from potential chromosomal
positional eﬀects (38). We therefore conclude that the
expression of integrated hTERT promoter in the targeted
BAC reporter recapitulated the activity of the native
promoter.
Chromatin structures of the hTERT promoter in
targeted BAC reporters
To determine the chromatin structures of the targeted
BAC reporter, DNase I assays were performed to examine
the integrated hTERT promoter. Nuclei from targeted
clones 167b3.1#2, GM639.6#9 and GM847.7#5 were
treated with DNase I and genomic DNA fragments were
analyzed by Southern analysis for the presence of DNase I
hypersensitive sites (DHSs) using a Rluc probe, which was
speciﬁc for the integrated hTERT promoter. As shown in
Figure 4, the integrated hTERT promoter coincided with
a DHS (1.5kb) in both 167b3.1#2 and GM639.6#9 cells,
consistent with active transcription from the hTERT pro-
moter in these tel
+ cells. In contrast, the hTERT pro-
moter was not sensitive to DNase I in tel
  GM847.7#5
cells. Furthermore, two extra DHS bands (2.6 and 3.1kb)
were also identiﬁed in 167b3.1#2 cells, corresponding to
DHSs at 1.1-kb and 1.6-kb upstream of the hTERT pro-
moter, respectively. A closer examination of our pre-
viously published data indicated the presence of these
two DHSs at the endogenous hTERT locus in 3C167b
cells [Figure 4 in (13)]. Since these upstream DHSs were
not present in GM639 and GM847 cells, they might
contain binding sites for transcription activators and con-
tributed to the higher level of hTERT transcription in
3C167b cells. Taken together, our experiments indicated
that the hTERT promoter in integrated BAC recapitu-
lated its endogenous promoter in host cells at the chro-
matin level.
Table 2. Transcription from integrated and native hTERT promoters
Acceptor lines
(targeted clones) Rluc
a Fluc
a Rluc/Fluc
Endogenous hTERT mRNA
b
hTERT/18S hTERT/CRR9
166a11.1 (tel
 )
c 13.2 7.8 404 137 0.04 0.03 0.02 0.01 0.07 0.04
#8 14.4 0.4 187 3 0.08 0.00
#15 9.5 0.4 392 1 0.02 0.00
#26 3.8 0.7 401 2 0.01 0.00
#27 13.1 0.3 547 10 0.02 0.00
#47 25.1 0.4 492 6 0.05 0.00
167b3.1 (tel
+)
c 944 575 559 112 1.63 0.71 104 10 720 71
#1 720 47 520 38 1.39 0.09
#2 1968 40 687 1 2.86 0.06
#3 589 13 483 13 1.22 0.03
#4 697 39 439 25 1.59 0.09
#10 746 27 668 33 1.12 0.04
GM847.1 (tel
 )
c 5.9 2.7 484 129 0.01 0.00 0.02 0.01 0.03 0.01
#26 4.0 0.8 392 3 0.01 0.00
#27 7.8 2.1 576 15 0.01 0.00
GM847.7 (tel
 )
c 19 5 476 107 0.04 0.02
#5 12 1 628 40 0.02 0.00
#6 21 2 437 13 0.05 0.01
#7 24 2 338 10 0.07 0.01
#18 16 1 519 28 0.03 0.00
#19 20 4 458 5 0.04 0.01
GM639.3 (tel
+)
c 93 35 279 48 0.33 0.10 62 37 5  4
#1 67 7 241 22 0.28 0.03
#2 69 6 221 6 0.31 0.03
#4 119 2 281 13 0.42 0.01
#5 67 12 331 12 0.20 0.04
#8 142 8 318 17 0.45 0.02
GM639.6 (tel
+)
c 233 96 791 55 0.29 0.12
#9 387 17 834 25 0.46 0.02
#10 194 33 790 126 0.25 0.04
#11 145 17 857 44 0.17 0.02
#25 176 8 744 24 0.24 0.01
#26 261 10 730 45 0.36 0.01
The bold numbers in these rows are averages of the numbers below.
aRelative levels of luciferase activities were normalized to amounts of live cells as determined by MTT assays.
bRelative levels of endogenous hTERT mRNA in parental immortal lines were determined by reverse transcription and quantitative PCR, normal-
ized to either 18S ribosomal RNA or CRR9 mRNA.
cAverage luciferase activities in targeted clones at the same acceptor line.
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Independent clones with the hTERT BAC reporter
targeted at the same acceptor site had identical genomic
contexts and were thus expected to have the same pro-
moter activity. Although diﬀerences of Rluc activity
among clones derived from the same acceptor lines were
relatively small, as compared to the disparities between
tel
+ and tel
  cells (Table 2), such diﬀerences were repro-
ducible in repeated experiments (data not shown). In fact,
we observed a tendency of increase in clonal variations
upon passaging cells, especially among clones of tel
+
167b cells. To determine whether DNA methylation was
a cause of such clonal variations, ﬁve-targeted clones
derived from the 167b3.1 acceptor line were treated with
5-azacytidine (5-AC). 5-AC is a potent inhibitor of DNA
methyltransferases DNMT1 and DNMT3a and known
to induce demethylation and reactivation of a number of
silenced genes (39,40). As shown in Figure 5, Rluc to Fluc
ratio ranged 1–5 prior to 5-AC treatment. Immediately
following treatment with 0.5mM 5-AC for 9 days, the
ratio of Rluc to Fluc increased signiﬁcantly in all ﬁve
clones and reached 3–7, suggesting that DNA methylation
contributed to the suppression of integrated hTERT pro-
moter in these clones. Interestingly, when these treated
cells were cultured in the absence of the drug for 12
days, the Rluc to Fluc ratio reduced to about 2 in all
clones. Further culturing of these cells led the Rluc/Fluc
ratios to diverge again. Therefore, accumulated DNA
methylation during cell proliferation was likely the cause
of clonal variations among the BAC reporters integrated
at the same chromosomal site.
DISCUSSION
Chromatin structures and epigenetic marks are ultimately
determined by the underlining primary DNA sequences
and the diﬀerentiation status of host cells. It has become
increasingly evident that such chromatin and epigenetic
mechanisms are critical for the regulation of gene expres-
sion. We have previously shown that randomly integrated
BAC reporter of the hTERT gene, similar to the reporter
used in this study, was able to undergo silencing upon
osteogenic diﬀerentiation of mouse embryonic stem cells
(28). However, uncontrolled random reporter integration
was inadequate for analyzing cis-regulatory elements,
because each integration event diﬀered in chromosomal
position eﬀects, copy numbers, and structural integrities,
making it diﬃcult to further dissect the regulatory
sequences via deletions and site-directed mutagenesis.
To establish a system for such mechanistic studies, we
developed the strategy of retrovirus-directed recombi-
nase-mediated BAC targeting or RMBT. First, clones
with a single-copy acceptor locus were created by retro-
viral transduction and neomycin selection. Second, large
BAC constructs, upon transfection into cells, integrated
into the acceptor sites via Cre-lox mediated recombination
and a puromycin/ganciclovir selection scheme. This tar-
geted integration procedure was highly eﬃcient, as the
majority of isolated clones contained the entire BAC
reporter at the acceptor site. This eﬃciency was further
increased with additional screening for the luciferase activ-
ities. We compared luciferase expression of the BAC
reporters targeted at six acceptor loci in four diﬀerent
cell lines with their endogenous counterparts. Rluc expres-
sion from the integrated hTERT promoter largely corre-
lated with the endogenous hTERT mRNA levels in host
cells, whereas Fluc expression from the CRR9 promoter
was similarly high in all cell lines. The ratio of Rluc to
HincII
EcoRI
DNase I
167b3.1#2 GM639.6#9 GM847.7#5
1.5
2.6
3.1
5.4 kb –3.9
 kb
+1.5
  kb
Figure 4. DNase I sensitivity of the hTERT promoter in integrated
BAC. Nuclei were treated with 0, 2, 4, 8 and 16 units/ml DNase I
for at 378C for 20min. Genomic DNAs were isolated, digested with
EcoR I and Hinc II, analyzed by Southern analysis using the Rluc
sequence as the probe. A diagram of the integrated hTERT promoter
is shown on the left, in which the black rectangle represents a portion
of the ﬁrst hTERT exon. The white rectangle shows part of the Rluc
sequence, and the thin arrow shows the transcription start site (TSS)
and direction. The thick arrow designates the 5.4-kb EcoR I-Hinc II
full-length genomic band. The positions of restriction sites are relative
to the TSS. The closed triangles denote the 1.5-kb DHS bands at
the hTERT promoter. The two open triangles indicate the two addi-
tional hypersensitive bands (2.6kb and 3.1kb) in 167b3.1 cells, corre-
sponding to DHSs that are 1.1-kb and 1.6-kb upstream of the hTERT
promoter. The sizes of DNase I hypersensitive bands are indicated
by numbers in kb.
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Figure 5. Eﬀects of inhibition of DNA methylasetransferases on
hTERT promoter reporter activities in integrated BACs. Five
3C167b3.1 clones containing the BAC reporter at the same acceptor
locus were treated with 0.5mM 5-AC for 9 days and luciferase activities
were determined. Pre-treatment, 5-AC treatment, 12-day, and 20-day
post-treatment: immediately before and after the 9-day treatment with
5-AC, 12 and 20 days after the completion of treatment, respectively.
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moter activity, thereby paralleled the endogenous hTERT
mRNA level. The luciferase expression data, together with
the formation of multiple DHSs at and upstream of the
integrated hTERT promoter, indicated that expression of
the endogenous hTERT promoter in host cells was reca-
pitulated by that of the transgenic BAC reporter, whereas
all previous attempts to model the endogenous hTERT
expression by transiently transfected reporters were unsuc-
cessful (11,13).
During initial experimental designing, we included a
hormone inducible Cre recombinase (CreER) in the accep-
tor cassette as the source of recombinase activity. While
the Cre activity was induced by tamoxifen in acceptor
lines, the hormone treatment also caused signiﬁcant cell
death in a subset of cell lines, especially tel
  ALT cells.
Thus, a transiently transfected Cre-expressing plasmid was
used to supply the recombinase activity. Nevertheless,
compared to their parental cells, the pre-targeted acceptor
cell lines did not show any change in the rate of cell pro-
liferation in the absence of hormone. Besides, the entire
cassette was excised upon targeted integration of the BAC
constructs. Therefore, although the CreER ORF will be
removed in future experiments, we reasoned that the pres-
ence of CreER sequence in the pre-targeted acceptor loci
would not have any eﬀects on the interpretation of the
data from current experiments.
Although an integrated BAC reporter at the same
acceptor site would be expected to adopt the same chro-
matin conﬁguration in independent clones, we did detect,
albeit relatively small, diﬀerences in reporter activities
among these clones. As shown in Figure 5, these clonal
variations were largely eliminated by a transient inhibition
of DNA methyltransferases, suggesting that the variations
were caused by DNA methylation accumulated during
cell proliferation.
It has been reported that the hTERT promoter
subjected to methylation in cultured cells and many
cancer-derived cell lines, but the reported eﬀects of
DNA methylation on hTERT transcription were variable.
Whereas some studies showed that methylation of the
hTERT promoter had negative or no eﬀect on hTERT
regulation (41,42), another study demonstrated that
hypermethylation of the hTERT promoter correlated
with higher telomerase expression level in cancer cells
(43). Although our previous data showed that transcrip-
tional silencing of the hTERT gene did not require CpG
methylation at its promoter (28), our current study sug-
gested that DNA methylation was likely a cause of varia-
tions in hTERT promoter activation in tel
+ cells. For
example, Rluc expression in the 3C167b#2 clone was ini-
tially higher than in its sibling clones. Interestingly, fol-
lowing the 5-AC treatment and recovery, its Rluc activity
returned to a level very similar to those of its sibling
clones. This result indicated that stochastic methylation
of speciﬁc cis-elements in the BAC reporter, such as
repressors of the hTERT promoter, might lead to an
increase of the hTERT reporter promoter activity in
3C167b3.1#2 cells. Alternatively, DNA methylation
could inactivate a negative trans regulator and thus indir-
ectly activated the hTERT promoter. However, the
endogenous hTERT mRNA level in 3C167b3.1#2 cells
was similar to that in other 3C167b clones (data not
shown), suggesting that the second possibility was
unlikely.
Despite the minor variations, analysis of gene expres-
sion using RMBT provides many advantages over conven-
tional methods. First, cis-acting elements, such as
enhancers, chromatin barriers/insulators, and locus con-
trol regions, may be dispersed over hundreds of kilobases
from the promoter (44). Small plasmid reporters are there-
fore not suited for studying the structures and functions of
these chromatin elements in their native contexts. BAC
constructs contain up to 300kb of genomic sequences
and likely include all of such distal chromatin elements.
Second, integration of the BAC reporters allows the DNA
to be assembled as part of the chromosomes. BAC con-
structs often contain suﬃcient sequences to establish a
chromatin environment that is similar, if not completely
identical, to their endogenous counterparts. Third, a single
copy of the BAC reporter is integrated at the acceptor
locus. Thus, the presence of integrated sequence unlikely
alters the stoichiometry of sequence-speciﬁc DNA-binding
factors. Single-copy integrations also allow easier detec-
tion of unintended rearrangements within the integrated
reporter and ensure its structural integrity. Most impor-
tantly, modiﬁed BAC constructs, containing deletions or
other mutations, can be reproducibly integrated into the
same acceptor sites and evaluated in the same genetic and
chromatin context.
Recently, several other groups have reported methods
for site-speciﬁc integration of large DNA constructs. For
example, Dafhnis-Calas et al. reported the ﬁrst site-speci-
ﬁc integration of BAC constructs by RMCE using øC31
and Cre recombinases (24). For studying gene regulation,
Wallace et al. reported the replacement of an 85-kb mouse
genomic fragment containing the a-globin gene cluster
with a 117-kb human synthetic sequence by recombi-
nase-mediated genomic replacement, or RMGR (22).
RMGR involved two gene-targeting procedures to insert
lox sites at both ends of a genomic region, which was
subsequently replaced by a pre-engineered BAC sequence
via Cre-mediated recombination. Prosser et al. introduced
an acceptor containing loxP and lox511 sites into the Hprt
locus in a mouse embryonic stem cell line, in which a BAC
containing myosin VIIa gene was subsequently integrated
(21). Similar to RMBT, these techniques oﬀered well-
controlled experimental approaches to study the genetic
and epigenetic regulation of a chromosomal segment.
However, these strategies were not readily adaptable for
studies of other genomic loci in a large variety of cell
types.
In this regard, RMBT is a novel approach and possesses
several advantages in its eﬃciency and general applicabil-
ity. First, retroviral transduction of acceptor sites is a
much simpler procedure and can be used in diﬀerent cell
types, including those where homologous recombination
is diﬃcult to achieve. Second, RMBT takes advantage of
the existing loxP/lox511 sites in the BAC vector back-
bones. Retroﬁtting most BAC clones for RMBT requires
only a single recombineering step. Third, a pair of cHS4
insulators was designed to surround the entire acceptor
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the scope of this study, we did not provide the data
supporting that these insulators functioned to reduce
chromosomal position eﬀects on the targeted BAC loci.
However, numerous previous reports have demonstrated
that similarly positioned cHS4 insulators protected retro-
virus vectors from chromosomal position eﬀects and
increased the probability of retroviral expression at vari-
ous chromosomal integration sites (36,45). Finally, com-
pared to previously published methods, the targeting
eﬃciency of RMBT was very high. In fact, all transfec-
tions for each speciﬁc targeting described in this study
were performed at small scales (10
5 cells and 1–2mgo f
BAC DNA in 6-well plates), and thus handling a relatively
large number of diﬀerent BAC constructs in several cell
types simultaneously is feasible.
In conclusion, the RMBT strategy is highly eﬃcient
and versatile for targeted single-copy integration of
large BAC constructs. Combined with mutagenesis of
BAC constructs using recombineering (14), the method
would oﬀer a genetically amendable system for dissecting
the chromatin-dependent and epigenetic mechanisms of
hTERT gene regulation as well as the regulation of
many other genes in their native genomic contexts.
In addition, the strategy can also be adapted to study
regulatory elements for DNA replication and DNA
damage repair in vivo, and to generate transgenic animals
by inserting large BAC constructs into deﬁned chromo-
somal loci.
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